Buy this pot stock for a double, analyst says

Roth Capital analyst Bill Kirk maintained a “Buy” rating and $5.00 target on High Tide (High Tide Stock Quote, Chart, News, Analysts, Financials NASDAQ:HITI), citing record Remexian volumes and a new C$40-million financing package.

High Tide is a Canadian retailer, distributor and e-commerce provider of regulated cannabis products and related accessories.

Kirk said Remexian sold about 7.6 tonnes of medical cannabis into Germany in fiscal Q2, up 21 per cent from six tonnes in Q1 and 49% year-over-year. He said the result implies roughly 15% market share in Germany, up from about 10% in Q1, and reduced aged inventory to about three tonnes from a peak of roughly 17 tonnes in late 2025.

The analyst said Remexian’s performance has improved materially since High Tide announced the acquisition, before the benefit of sourcing improvements tied to more Canadian product.

Separately, High Tide announced a C$40-million financing package, including a C$25-million revolver and C$15-million delayed-draw term loan. Kirk said the package retires about C$6-million of existing debt, leaves C$19-million of flexibility and could allow the company to refinance higher-cost junior debt in 2027.

Kirk said High Tide’s success in Germany could also become more relevant if the U.S. eventually allows cannabis exports.

Kirk expects High Tide to generate $50.5-million in Adjusted EBITDA on revenue of $712.9-million in fiscal 2026.

-30-